MDGL   $233.86  -3.46% Market Closed After Close 233.49 -0.16%

Madrigal Pharmaceuticals Inc
Total Cash 1.06B
totalCashPerShare 48.718
EBITDA -529.57M
Total Debt 118.06M
quickRatio 8.507
currentRatio 8.723
Total Revenue 14.64M
debtToEquity 13.775
Revenue/Share 0.735
ROA -0.47271
ROE -1.06274
grossProfits
freeCashflow -278.01M
operatingCashflow -448.96M
earningsGrowth
revenueGrowth
grossMargins 0.95655
ebitdaMargins 0.0
operatingMargins -11.103769
profitMargins 0.0
enterpriseValue 4.31B
forwardPE -12.806731
floatShares 10.57M
sharesOutstanding 21.71M
sharesShort 3.76M
sharesShortPriorMonth 3.68M
dateShortInterest
sharesPercentSharesOut 0.17%
heldPercentInsiders 0.15%
heldPercentInstitutions 1.06%
Short Ratio help_outline 13.16%
shortPercentOfFloat 0.25%
impliedSharesOutstanding
bookValue 39.497
Price To Book help_outline 5.97
earningsQuarterlyGrowth
netIncomeToCommon -510.45M
trailingEps -25.56%
forwardEps -18.42%
enterpriseToEbitda -8.14
lastDividendValue
lastDividendDate
currentQuarterEstimate -7.09 3Q 2024
institutionsCount 351
lastUpdated Sept. 16, 2024, 7:59 p.m.